Sec Form 5 Filing - Reyes Susan Raymundo @ Healthcare Integrated Technologies Inc. - 2024-07-31

FORM 5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Reyes Susan Raymundo 2. Issuer Name and Ticker or Trading Symbol Healthcare Integrated Technologies Inc. [ HITC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Medical Officer (Last) (First) (Middle) 743 FOX LANDING LANE 3. Date of Earliest Transaction (MM/DD/YY) 07/31/2024 (Street) KNOXVILLE, TN37922 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 07/31/2023 A( 1 ) 1,516,666 A $ 0.11 1,516,666 D Common Stock 07/31/2024 A( 2 ) 258,360 A $ 0.1 258,360 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Holdings $ 0.4 ( 3 ) 09/01/2020 09/01/2025 Common Stock 150,000 150,000 D Holdings $ 0.4 ( 3 ) 09/01/2021 09/01/2025 Common Stock 283,333 283,333 D Holdings $ 0.4 ( 3 ) 09/01/2022 09/01/2025 Common Stock 283,333 283,333 D Holdings $ 0.4 ( 3 ) 09/01/2023 09/01/2025 Common Stock 283,334 283,334 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Reyes Susan Raymundo 743 FOX LANDING LANE KNOXVILLE, TN37922 Chief Medical Officer Signatures /s/ Susan R. Reyes 08/07/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On July 31, 2023, the Board of Directors of the issuer approved the issuance of 1,516,666 shares of common stock to the Reporting Person as payment for compensation owed to her as of July 31, 2023 under her Employment Agreement dated September 1, 2020. ( 2 )On July 31, 2024, the Board of Directors of the issuer approved the issuance of 258,360 shares of common stock to the Reporting Person as payment for compensation owed to her as of July 31, 2024 under her Employment Agreement dated January 31, 2024. ( 3 )On September 1, 2020, the Reporting Person was appointed Chief Medical Officer of the issuer. Upon execution of an Employment Agreement dated on such date, the Reporting Person was awarded 1,000,000 common stock purchase options, all of which are currently vested.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.